PFE
What one share of Pfizer holds
Pharmaceutical Preparations
Pfizer Inc. is a research-based, global biopharmaceutical company. We apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of
Pfizer’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-28; the balance sheet is as of 2026-06-28.
| Sales | $11.12 |
|---|---|
| Profit | $0.76 |
| Capex (buildings and equipment) | $0.42 |
| Free cash flow | $1.92 |
| Dividends | $1.72 |
| Cash and investments | $0.17 |
| Debt | $11.07 |
| Book value | $14.95 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $8.58 | $1.17 | $0.30 | $2.33 | $1.22 | $10.00 |
| 2017 | $8.67 | $3.52 | $0.32 | $2.45 | $1.30 | $11.98 |
| 2018 | $6.83 | $1.87 | $0.33 | $2.32 | $1.38 | $11.42 |
| 2019 | $7.21 | $2.82 | $0.36 | $1.86 | $1.46 | $11.38 |
| 2020 | $7.40 | $1.63 | $0.40 | $2.16 | $1.53 | $11.34 |
| 2021 | $14.24 | $3.85 | $0.47 | $5.23 | $1.57 | $13.73 |
| 2022 | $17.65 | $5.47 | $0.56 | $4.54 | $1.61 | $17.02 |
| 2023 | $10.43 | $0.37 | $0.68 | $0.84 | $1.65 | $15.76 |
| 2024 | $11.16 | $1.41 | $0.51 | $1.73 | $1.69 | $15.56 |
| 2025 | $10.95 | $1.36 | $0.46 | $1.59 | $1.72 | $15.21 |